Updates

Health Risks in Sikar and Bharatpur: Children Affected by Contaminated Syrup
A troubling incident in Sikar and Bharatpur has raised alarm over children's health, as multiple cases of adverse symptoms linked to syrup consumption have been reported.

Somerset Indus Completes Full Exit from Apex with Advay Capital's Guidance
Somerset Indus has successfully exited its stake in Apex, facilitated by Advay Capital Advisors. This strategic move marks a significant milestone for both companies, highlighting the strength of Advisory partnerships in financial transactions.

Considerations for Regulating Chatbot Marketing and User Safety
Learn about potential regulations on chatbot marketing, user safety measures, and company accountability to address mental health concerns.

Waiver of Local Trials for Hepatitis C Antivirals by CDSCO
The Central Drugs Standard Control Organisation (CDSCO) waives local trials for antiviral drugs against Hepatitis C, streamlining access and approval processes. Discover how this decision impacts patient care and drug availability today!

Projected Surge in Global Cancer Deaths: A Lancet Report
Discover alarming projections from 'The Lancet' revealing a potential 75% increase in global cancer deaths over the next 25 years. Understand the implications and what it means for global health policies.

Benefits of Rational Medicine Use for Policyholders
Discover how rational medicine and diagnostics can reduce out-of-pocket expenses for policyholders while promoting quicker recovery and fewer complications in healthcare.

Building a Patient-Centric Future in Healthcare Leadership
Dr. Advani on Elevating Patient Care through Effective Leadership

Advanced Surgical Systems for Complex Cancer Procedures
Enhance Precision in High-Stakes Cancer Surgeries with Our Advanced Systems

Tata AIG Suspends Cashless Services at Max Hospitals: Key Insights
Tata AIG's suspension of cashless services at Max hospitals has raised concerns. Inquiries reveal the insurer's demand for sudden tariff cuts, impacting policyholders and hospital operations.

Understanding the Diabetes Epidemic in India: Facts and Figures
Discover the alarming statistics of diabetes in India. With 77 million adults affected by Type 2 diabetes and another 25 million at risk, learn how this health crisis impacts the nation and what can be done about it.

Total Investment of ₹15,034.50 Crore for Development Schemes (2025-2029)
Discover the financial commitment towards development schemes totaling ₹15,034.50 crore from 2025-29, with the central government contributing ₹10,303.20 crore and states providing ₹4,731.30 crore. Learn more about the impact of this investment.

The Future of Diagnostics in India: Embracing Digital and Precision Medicine
Revolutionizing Patient Care in India with Digital Diagnostics Solutions
